Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology.

about

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring.

P2860

Q37307952-703DF040-FF2E-46BF-913B-AFAFC965E955

P2860

Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology.

Item

http://www.wikidata.org/entity/Q38068491

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Bringing cancer serological di ...... ing and neoepitope technology.

@en

type

Item

label

Bringing cancer serological di ...... ing and neoepitope technology.

@en

prefLabel

Bringing cancer serological di ...... ing and neoepitope technology.

@en

P1476

Bringing cancer serological di ...... ding and neoepitope technology

@en

P2093

Anne C Bay-Jensen

http://www.w3.org/2001/XMLSchema#string

Jianxia Wang

http://www.w3.org/2001/XMLSchema#string

Morten A Karsdal

http://www.w3.org/2001/XMLSchema#string

Qinlong Zheng

http://www.w3.org/2001/XMLSchema#string

Ying Xue

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer cells cut homophilic cell adhesion molecules and run

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

A molecular view of anti-ErbB monoclonal antibody therapy

Biomarkers in cancer staging, prognosis and treatment selection

MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay

Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

P304

35-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.12.161

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas Willumsen

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23252562

http://www.w3.org/2001/XMLSchema#string

Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology.

about

P2860

P2860

Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698